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Fold change with age (log2) d14/d3 vs. d18/d3: r = 0.85 d14/d3 vs. d16/d3: r = 0.69 d16/d3 vs. d18/d3: r = 0. (A) Fold changes in insolubility with age in animals treated with control RNAi are plotted for three biological replicates. Spearman r correlation r= 0.77 d18/d3 versus d16/d3, r= 0.85 d18/d3 versus d14/d3 and r= 0.67 d14/d3 versus d16/d3; two-tailed p-value p<0.0001 d18/d3 versus d16/d3, p<0.0001 d18/d3 versus d14/d3 and p<0.0001 d14/d3 versus d16/d3. (B) Fold changes in insolubility with age in animals treated with daf-2 RNAi are plotted for three biological replicates. Spearman r correlation r= 0.87 d18/d3 versus d16/d3, r= 0.86 d18/d3 versus d14/d3 and r= 0.82 d14/d3 versus d16/d3; two-tailed p-value p<0.0001 d18/d3 versus d16/d3, p<0.0001 d18/d3 versus d14/d3 and p<0.0001 d14/d3 versus d16/d3. (C) Sypro Ruby whole protein staining of [SDS-soluble + SDS-insoluble] fraction and SDS-insoluble fraction from day 3 and day 18 gon-2(-) mutants exposed to control and daf-2 RNAi (grown at 25°C 
Control RNAi (A) Zoom into the procorpus of tagRFP::PAB-1 expressed in the pharyngeal muscles showing cytoplasmic and nuclear tagRFP::PAB-1 stress granules upon heat stress (2h, 32°C) at day 1 of adulthood. tagRFP::PAB-1, day 11
daf-2
wild-type In category "Control RNAi aged/young" bold highlights insoluble proteins with more than 2 fold accumulation with age in control conditions. In category "daf-2 RNAi aged/young" bold highlights proteins which aggregate with age in daf-2(-) conditions (>1.2 fold), underlined highlights proteins with reduced aggregation with age in daf-2(-) conditions (<0.83 fold). ) RNA-binding proteins previously shown to localize to stress granules or P-granules in the literature (including references to their homologs in other organisms). [pdnj-19::dnj-19::yfp] Maintenance: All strains were maintained at 15°C by standard techniques on NGM plates seeded with OP50. Day 1 of adulthood is defined as 24h after the last larval stage L4. Before each experiment, adults of the desired strains were transferred to 20°C and their progeny selected at L4 stage to achieve synchronization. For experiments with worms carrying mutations as well as DCD212, DCD226, DCD194, DCD219 strains, the adults were maintained at 15°C, their progeny picked at L4 stage and thereafter transferred to 20°C.
Lifespan analysis:
Worms were grown on OP50 seeded NGM plates at the experimental temperature indicated and were scored every day for live animals, dead animals (no longer responding to body touch) and censored animals (crawled off plates, contaminated, ruptured or showing internal hatching). For lifespan analysis under mild stress, worms were grown at 20°C and transferred to 25°C at day 7. Survival analyses were performed using the Kaplan-Meier method using an online application for survival analysis (Yang et al., 2011) .
Movie acquisition:
Movies were taken for 60 seconds of worms on NGM plates without bacteria using a Leica M165 FC microscope with a Planapo 2.0x objective and a Leica DFC310 FX camera. The videos were modified to play side by side at double playing speed using Vidiot software (https://sourceforge.net/projects/vidiot/).
RNAi treatment:
RNAi by feeding was performed as described previously (Hansen et al., 2005) . All RNAi clones were obtained from the Marc Vidal RNAi feeding library or the Julie Ahringer RNAi feeding library (Source BioScience, UK) and sequenced. HT115 containing the empty vector L4440 was used as control.
Cloning and Strain Generation:
Cloning was carried out using the Gateway system (Life Technologies, Darmstadt, Germany). Pmyo-2 promoter was kindly provided by Brian Lee, UCSF. tiar-2 cDNA was amplified from a cDNA library prepared from total RNA isolated from N2 worms. The pab-1 gene was amplified from N2 total DNA extract. All constructs contain the unc-54 3′ UTR. The tagrfp vector was obtained from Evrogen (AXXORA, San Diego, CA, USA). Venus was generated by targeted mutation of the yfp gene. Constructs were generated with fluorescent tags inserted either before or after the gene to avoid disrupting LC domain. Constructs were sequenced at each step. Pmyo-2::tagrfp::pab-1 was injected at 10 ng/µl (whole plasmid injected), ::venus at 30ng/µl together with the coinjection marker Punc-122::gfp at 100ng/µl (whole plasmids injected). Undiluted PCR amplified Pmyo-2::venus::tiar-2 was injected at 10 ng/µl to generate transgenics. All constructs were injected into N2 animals. To avoid the vector backbone, constructs were amplified by PCR with the following primers: Primer 1 (T3) ATTAACCCTCACTAAAGGGA and primer 2 TTAAGTTGGGTAACGCCAGG. Stable lines expressing PAB-1 were generated by irradiating the animals containing the extrachromosomal array in a CL-1000 Ultraviolet Crosslinker (UVP) with 275µJ x 100. 100% transmission line was backcrossed four times into the wild-type N2 strain. Non-integrated strains expressing DNJ-13::YFP and DNJ-19::YFP were obtained from Klaus Richter (Papsdorf et al., 2014) and integrated by gamma irradiation following standard procedures. These strains were then backcrossed three times into the wild-type N2 strain.
Imaging and immunofluorescence staining:
Fixation protocols for direct confocal analysis or immunohistochemistry were adapted from a fixation protocol previously described (Antibody Staining of C. elegans by Michael Koelle, https://medicine.yale.edu/lab/koelle/protocols/Antibody%20Staining_180540_21947.pdf). Worms at the desired age and after treatment were picked into M9 containing OP50 and then washed once with H 2 O before being resuspended in fixation solution containing 1% PFA. After mixing thoroughly, worms were immediately immersed into liquid nitrogen for freezing. Tubes were thawed at 70°C and refrozen in dry ice two times and then rotated overnight at 4°C. For direct confocal analysis worms were washed hereafter with PBST-B and optionally stained with Hoechst33342 stain (NucBlue Live Cell Stain Ready Probes Reagent, Life Technologies) for 20 minutes before washing again and mounting them on slides using Fluorescent Mounting Medium (Dako). For immunohistochemistry, worms were permeabilized and stained as previously described using PAB-1 antibody (1:200, (Scheckel et al., 2012) ) and AlexaFluor488 conjugated anti-rabbit (Invitrogen) diluted 1:200 as secondary antibody. Worms were stained with Hoechst33342 for 20 minutes and placed on a slide using Fluorescent Mounting Medium (Dako). Worms were examined under a Leica SP8 confocal microscope with the HC PL APO CS2 63x1.40 oil objective using the Leica HyD hybrid detector. In single transgenics, tagRFP was detected using 555nm as excitation and an emission range from 560-650nm, Venus with 514nm as excitation wavelength and an emission range from 520-570nm. In double transgenic animals emission ranges were narrowed to 570-600nm for tagRFP and 521-551nm for Venus to prevent detection of cross-emission. Hoechst33342 staining was visualized with an excitation of 405nm and an emission range from 430-500nm. Alexa Fluor488 antibody was excited with 488nm and detected with an emission range from 500-550nm. 3D reconstructions were performed using the Leica Application Suite (LAS X). Puncta size of single plane images was determined using Fiji software (Schindelin et al., 2012) .
FRAP analysis:
FRAP analysis was performed as previously described (David et al., 2010) using the Leica SP8 confocal microscope with the HC PL APO CS2 63x 1.30 glycerol objective and PMT detector. Bleach settings: 4x 20% for PAB-1 and TIAR-2 puncta. tagRFP: 555nm excitation, 565-620nm emission. Venus: 514 excitation, 521-551nm emission. Relative fluorescence intensity (RFI) was analyzed as described previously following the equation RFI = (Tt/Ct)/(T0/C0), where T0 is the intensity in the region of interest (ROI) before photobleaching; Tt, the intensity in the ROI at a defined time after photobleaching; C0, the intensity in the non-bleached part of the puncta before photobleaching; and Ct, the intensity in the non-bleached part of the puncta after bleaching (Brignull et al., 2006) .
Insoluble protein extraction:
To isolate SDS-insoluble proteins for mass spectrometry analysis, we performed a sequential extraction as previously described (David et al., 2010) . 350mg ground worms per treatment were solubilized in two volumes of a high salt RAB buffer (0.1 M MES, 1 mM EGTA, 0.1 mM EDTA, 0.5 mM MgSO4, 0.75 M NaCl, 0.02 M NaF, 1 mM PMSF, Roche Complete Inhibitors 2x, DNaseI and RNaseI). High-salt soluble proteins were removed by centrifugation with 20 000g, 20 minutes at 4°C. The pellet was reextracted in RAB buffer with 1 M sucrose to help remove lipids and then resuspended twice in two volumes of RIPA buffer (50 mM Tris pH 8, 150 mM NaCl, 5 mM EDTA, 0.5% SDS, 0.5% SDO, 1% NP-40, 1 mM PMSF, Roche Complete Inhibitors 1x). Detergent soluble proteins were removed by centrifugation with 20 000g, 20 minutes at 4°C. This final pellet containing highly insoluble proteins was resuspended in 200µl 70% formic acid and centrifuged at 50 000g to remove worm cuticlar debris. To isolate insoluble proteins for western blot analysis, a simplified protocol was used where 50mg of ground animals in RAB buffer were directly resuspended in 150µl RIPA buffer. SDS-insoluble proteins were isolated by washing with RIPA buffer containing 0.5% SDS and centrifugation with 20 000g for 20 minutes at 4°C. To compare insoluble proteins collected by our method to those collected by Walther et al, we omitted SDS in the RIPA wash thus collecting both SDS-soluble and SDS-insoluble proteins after centrifugation with 500 000g for 10 minutes at 4°C as previously described (Walther et al., 2015) . For both extractions, we washed the pellet once in 100µl RIPA. Final pellets containing insoluble proteins were recovered in 75µl 8 M Urea, 2% SDS, 50 mM DTT, 50 mM Tris pH 7.4 at room temperature.
Insoluble protein extraction using C. elegans with gonads:
To investigate the effect of reduced daf-2 signaling on protein insolubility in animals with gonads, 550 N2 and CF1041 worms were grown at 20°C. Worms were collected at day 1 or day 11 in RAB buffer and homogenized with the Precellys Lysing Kit (Cayman Chemical) using 1.4 mm ceramic beads. After adding the homogenate into tubes without beads and centrifugation at 20,000g for 20 minutes at 4°C, the protein extraction was performed as described in "Insoluble protein extraction". SDS was omitted in the RIPA wash and centrifugations were performed at 20,000g.
Mass spectrometry analysis:
SDS-insoluble proteins dissolved in formic acid were further processed for mass spectrometry analysis as previously described (David et al., 2010) . Briefly, after dialysis, proteins were solubilized in final concentration of 8M Urea. After alkylation and reduction, samples were diluted in 150mM ammonium bicarbonate to obtain a final 2M Urea concentration. Proteins were digested by modified trypsin (Promega, Madison, WI) at 5% w/w overnight at 37°C. Peptides from young and aged animals on control and daf-2 RNAi were labelled by 4-plex iTRAQ following the manufacturer's instructions (Applied Biosystems, Pleasanton, CA, USA). We checked that over 95% of the peptides were labelled with iTRAQ by analysing the sample on a 1-h LC-MS/MS run and searching the spectra, allowing iTRAQ as a variable modification. In order to decrease sample complexity and improve identification, peptides were separated by SCX fractionation and desalted. A total of 46 SCX fractions were collected. Individual SCX fractions were separated on a reverse phase C18 (LC Packings, Sunnyvale, CA) and the LC eluate was coupled to a micro-ionspray source attached to a QSTAR Pulsar Elite mass spectrometer (Applied Biosystems, Foster City, CA) (Trinidad et al., 2013) . SCX fractions 1-20 contained relatively few peptides and were analysed by a single LC-MS analysis. To increase the coverage of peptides fractions 21-46 were analysed twice by LC-MS/MS. In the first analysis, only those ions with m/z between 375 and 600 were selected for data-dependent MS/MS, while in the second analysis, this range was between 590 and 1200 Da. MS/MS spectra were analysed as previously described (David et al., 2010) . We kept peptides that had at least one iTRAQ peak area over 25 counts. For proteins identified by one single peptide, peptides with an expectation value larger than 1E-3 were eliminated. For proteins identified by two or more peptides, we discarded peptides with an expectation value larger than 1E-2. The false positive rates were estimated by conducting the search using a concatenated database containing the original UniProt database as well as a version of each original entry where the sequence has been randomized. Using this stringent cut-off, we did not identify any decoy database proteins, indicating that the protein false discovery rate was much less than 1%. In the insoluble fractions, we detected a total of 438 proteins comparing extracts from day16/day3 old animals, 470 proteins comparing extracts from day18/day3 old animals and 492 proteins comparing extracts from day14/day3 old animals. To determine the relative level of each protein, we averaged the ratio of (peak area of sample of interest)/(sum of peak areas from all four conditions) for all peptides identified for each protein. To measure the fold change in levels of aggregation-prone proteins with age, we divided the ratio for aged control or aged daf-2 RNAi samples by the respective ratio for young control or young daf-2 RNAi samples. For further data analysis, we kept only proteins present in all three biological replicates and averaged their fold changes. Calculation of correlations between fold changes in insolubility between the repeats (Figure S1A and S1B) was performed using GraphPad Prism 6 software. Data was tested for normality with D'Agostino & Pearson omnibus normality test and Spearman r correlation was calculated as several data sets did not pass the normality test.
Western blotting analysis:
The following antibodies were used: anti-PAB-1 (1:60, (Scheckel et al., 2012) ), anti-HRP-1 (1:200, (Joeng et al., 2004) ), anti-CAR-1 (1:400, (Boag et al., 2005) ), anti-fibrillarin (1:1000, #2639, Cell Signaling), anti-HSP-90 (1:500, #4874, Cell Signaling) and anti-14-3-3 (1:5000, SC-1657, Santa Cruz Biotechnology). Bands detected by immunoblot or whole lanes detected by Sypro Ruby blot staining (Thermo Scientific) for total protein levels were quantified using Image J.
Bioinformatics analysis:
The C. elegans proteome set was prepared by obtaining all proteins identified by mass spectrometry available in PeptideAtlas 2011 (http://www.peptideatlas.org) with a PeptideProphet probability over 0.9. Proteins identified in our experiment but not in the PeptideAtlas database were added to this proteome set (final total: 7454 proteins). To exclude possible biases in sequence or structural properties due to the presence of transmembrane helices, we removed all proteins predicted to contain transmembrane helices using TMHMM v2.0 (Krogh et al., 2001) , resulting in 6102 proteins. To prevent bias due to redundancy, we reduced the sequence identity of the set
